Sun Pharmaceutical Industries Ltd. et al. v. Aurinia Pharmaceuticals Inc. > Summary
Court Case Number IPR2022-00617
Filing Date Feb 24, 2022
Institution Decision Date Jul 26, 2022
Decision Date Jan 25, 2023
Court Patent Trial and Appeal Board
Status Terminated-Settled
Administrative JudgesJeffrey N. Fredman, Ryan H. Flax, Timothy G. Majors
Judge Writing the Final DecisionJeffrey N. Fredman
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
Claims Instituted: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
Petitioner
Patent Owner
Petitioner Attorneys
3Patent Owner Attorneys
9Aurinia Pharmaceuticals Inc.
Attorney Name: William Esper
Finnegan, Henderson, Farabow, Garrett & Dunner
Aurinia Pharmaceuticals Inc.
Attorney Name: Collette Corser
Finnegan, Henderson, Farabow, Garrett & Dunner
Aurinia Pharmaceuticals Inc.
Attorney Name: Mark J. Feldstein
Finnegan, Henderson, Farabow, Garrett & Dunner
Aurinia Pharmaceuticals Inc.
Attorney Name: Joshua L. Goldberg
Finnegan, Henderson, Farabow, Garrett & Dunner
Aurinia Pharmaceuticals Inc.
Attorney Name: Stefan O. Ochiana
Finnegan, Henderson, Farabow, Garrett & Dunner
Aurinia Pharmaceuticals Inc.
Attorney Name: Neil Solomons
Wave Life Sciences
Aurinia Pharmaceuticals Inc.
Attorney Name: Abdul Halim Abdul Gafor
UKM Specialist Centre
Aurinia Pharmaceuticals Inc.
Attorney Name: Robert Huizinga
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc.
Attorney Name: Rosnawati Yahya
Sunway Medical Centre Sdn Bhd
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10286036 | Protocol for treatment of lupus nephritis | May 14, 2019 |
